Showing results (741-750 of 1,020) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|April 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study FindingsJames J Harding, Ralf Hofheinz, Elena Élez, et al.
Cancer Research Communications|April 14, 2026
Association between Clostridioides difficile Test Positivity and Colorectal Cancer Incidence in a Multisite Hospital-Based Retrospective Cohort AnalysisSamara Rifkin, Sean M Anderson, Xingyu Chen, et al.
Cancer Research Communications|August 11, 2026
Early EGFR inhibition triggers actionable tumour and microenvironmental remodelling in lung cancerAaron C Tan, Jia Chi Yeo, Jacob J S Alvarez, et al.
Cancer Research Communications|August 14, 2026
Antitumor activity of novel transcriptional inhibitors ecubectedin and PM54 in soft tissue sarcoma patient-derived xenograftsDaniël Gorgels, Chao-Chi Wang, Lore De Cock, et al.
Cancer Research Communications|August 26, 2026
Spindle Assembly Checkpoint Competency Determines Sensitivity to KIF18A Inhibition in Small-Cell Lung CancerChiori Tabe, Rajesh Kumar, Yue Huang, et al.
Cancer Research Communications|August 25, 2026
Patient-Level KRAS G12C Prevalence Among Hispanic/Latino and Non-Hispanic White Patients in Real-World Clinicogenomic CohortsDaniel F Pilco-Janeta, Myriam De la Cruz-Puebla, Daisy R Guamán-Pilco, et al.
Cancer Research Communications|September 24, 2026
Impact of BRCA alterations on Androgen Receptor pathway inhibition treatment outcome in advanced prostate cancerRuchi Chaudhary, Karen A Urtishak, Michael Gormley, et al.
Cancer Research Communications|September 24, 2026
Identification and validation of the ESR1 Y537S mutant-enriched enhancer and its downstream target IGFBP3Yonatan Amzaleg, Desirea Mecenas, Ebony Flowers, et al.
Cancer Research Communications|September 29, 2026
Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic TherapiesNadeem Bilani, Jesenia M Perez, Ana M Aparicio, et al.
Cancer Research Communications|October 8, 2026
Phase 1a Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS ExposureKarisa C Schreck, Bachchu Lal, Jianli Zhou, et al.
Pageof 102